又一上市公司因财务造假将被强制退市。 近日，中国证监会对上市公司立方数科股份有限公司（以下简称"立方数科"）涉嫌定期报告财务数 据存在虚假记载作出行政处罚及市场禁入事先告知。 经查，2021年至2023年，立方数科通过开展代理业务、融资性贸易、虚假贸易等方式，累计虚增收 入6.38亿元、成本6.28亿元。其中，2021年收入、成本分别虚增2.80亿元、2.77亿元，2022年收入、成本 分别虚增3.12亿元、3.05亿元，2023年收入、成本分别虚增0.46亿元、0.45亿元。立方数科连续3年虚增 收入和成本，严重违反证券法律法规，安徽证监局拟对立方数科处以1000万元罚款，对汪逸等10名责任 人合计罚款3000万元。立方数科涉嫌触及重大违法强制退市情形，深交所将依法启动退市程序。 同时，中国证监会决定对本案所涉会计师事务所执业行为立案调查，涉嫌未能勤勉尽责的将依法严 惩。 此案是上市公司领罚单，中介机构被同步立案的典型，体现了监管部门打击财务造假"追首 恶"与"打帮凶"并重的导向。南开大学金融发展研究院院长田利辉认为，监管部门对于财务造假的打 击，已经形成了"行政处罚+市场禁入+刑事移送+退市执行+中介追责 ...

华夏时报记者 帅可聪 北京报道 "连夜挂跌停板出货，还有逃跑的机会吗？"2025年11月28日深夜，一位投资者在ST立方（300344） （300344.SZ，下称"立方数科"）股吧中如此询问。在立方数科的3万名股东中，不少人正寝食难安。 11月28日晚间，立方数科发布公告称，公司当天收到证监会安徽监管局（下称"安徽证监局"）行政处罚 事先告知书，因被认定2021年至2023年连续三年财务造假，安徽证监局拟对公司及10名责任人罚款合计 4000万元，其中拟对公司罚款1000万元。 与此同时，证监会官网发布通报，立方数科严重财务造假案件，涉嫌触及重大违法强制退市情形，深交 所将依法启动退市程序。同时，证监会决定对本案所涉会计师事务所执业行为正式立案调查。对于可能 涉及的证券犯罪问题线索，将移送公安机关。 广东环宇京茂律师事务所徐越惠律师在接受《华夏时报》记者采访时表示，立方数科通过开展代理业 务、融资性贸易、虚假业务三种手段造假，使得公司财务报表完全失去了真实性和公允性。若正式处罚 落地，其造假行为将直接触发退市新规中的重大违法强制退市条款。投资者如因立方数科财务造假蒙受 损失，可依法起诉索赔。 三年虚增营收超 ...

据行政处罚事先告知书，安徽证监局查明，立方数科通过开展代理业务、融资性贸易、虚假贸易虚增营 业收入、营业成本、利润总额，导致立方数科披露的2021年至2023年年度报告存在虚假记载。 2025年4月28日，因定期报告涉嫌信息披露违法违规，立方数科被证监会立案调查。至此，历时7个月， 初步处罚结论终于出炉。 "连夜挂跌停板出货，还有逃跑的机会吗？"2025年11月28日深夜，一位投资者在ST立方（300344.SZ， 下称"立方数科"）股吧中如此询问。在立方数科的3万名股东中，不少人正寝食难安。 11月28日晚间，立方数科发布公告称，公司当天收到证监会安徽监管局（下称"安徽证监局"）行政处罚 事先告知书，因被认定2021年至2023年连续三年财务造假，安徽证监局拟对公司及10名责任人罚款合计 4000万元，其中拟对公司罚款1000万元。 广东环宇京茂律师事务所徐越惠律师在接受《华夏时报》记者采访时表示，立方数科通过开展代理业 务、融资性贸易、虚假业务三种手段造假，使得公司财务报表完全失去了真实性和公允性。若正式处罚 落地，其造假行为将直接触发退市新规中的重大违法强制退市条款。投资者如因立方数科财务造假蒙受 损失 ...

Core Viewpoint - ST Lifan (立方数科) has been found guilty of serious financial fraud over three consecutive years, leading to potential penalties and a forced delisting from the Shenzhen Stock Exchange [2][3][6]. Summary by Sections Financial Fraud Details - From 2021 to 2023, ST Lifan inflated its revenue by 638 million yuan and its costs by 628 million yuan through fraudulent activities including agency business, financing trade, and fictitious transactions [4][5]. - The specific annual inflation figures include 280 million yuan in 2021, 312 million yuan in 2022, and 46 million yuan in 2023 for revenue, and similar figures for costs [4]. Regulatory Actions - The Anhui Securities Regulatory Bureau has proposed a total fine of 40 million yuan, with 10 million yuan directed at the company and 30 million yuan against 10 responsible individuals [5]. - Key executives, including the chairman and general manager, face individual fines and potential market bans for their roles in the fraud [5]. Market Impact - Following the announcement, ST Lifan's stock price fell by 5.6% to 3.36 yuan per share, marking a significant decline of approximately 78% from its peak of 15.26 yuan earlier in the year [8][10]. - The company is expected to face a challenging market environment upon resuming trading after a one-day suspension [10]. Legal Implications for Investors - Investors who suffered losses due to the financial fraud may have the right to file lawsuits for compensation, particularly those who bought shares between April 25, 2022, and April 29, 2025 [10][11].

Core Viewpoint - ST Lifan is facing severe financial fraud allegations, which may lead to its delisting from the stock market due to continuous financial misconduct from 2021 to 2023 [2][5][10]. Financial Misconduct - From 2021 to 2023, ST Lifan inflated its revenue by a total of 638 million yuan and costs by 628 million yuan through various fraudulent activities [10]. - The breakdown of inflated figures includes: - 2021: Revenue inflated by 280 million yuan, costs inflated by 277 million yuan - 2022: Revenue inflated by 312 million yuan, costs inflated by 305 million yuan - 2023: Revenue inflated by 46 million yuan, costs inflated by 45 million yuan [10]. Regulatory Actions - The Anhui Securities Regulatory Bureau plans to impose a total fine of 40 million yuan on ST Lifan and related responsible individuals due to the financial fraud [5]. - ST Lifan has been warned and fined 10 million yuan, while 10 responsible individuals, including the chairman and general manager, face a combined fine of 30 million yuan and a 10-year market ban [10]. - The case involving the accounting firm associated with ST Lifan is under formal investigation for failing to fulfill its duties [10]. Delisting Risk - ST Lifan is at risk of being forcibly delisted due to serious violations of securities laws, with the Shenzhen Stock Exchange initiating delisting procedures [5][12]. - The company's stock will be suspended from trading starting December 1 and will be subject to delisting risk warnings upon resumption [12]. Financial Performance - ST Lifan has reported continuous losses over the years, with a recent financial summary indicating a total revenue of 2.03 billion yuan and a net loss of 620 million yuan for the latest reporting period [14]. - The company has seen a decline in its stock price, closing at 3.36 yuan per share, with a total market capitalization of 2.2 billion yuan as of November 28 [15]. Shareholder Information - As of October 20, ST Lifan had over 30,000 shareholders, with a slight decrease in the number of shareholders noted in recent periods [16][17].

Core Viewpoint - Lifan Shuke (300344.SZ) faces significant regulatory scrutiny due to a negative internal control audit report from Zhongxing Caiguanghua Accounting Firm, leading to a one-day stock suspension and subsequent risk warnings [1][2][4] Group 1: Regulatory Actions - The company received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into potential information disclosure violations [1][2] - Following the audit report, the company's stock will be renamed to "ST Lifan," indicating a warning status due to the identified internal control deficiencies [1][4] Group 2: Financial Performance - In the 2024 annual report, Lifan Shuke reported revenue of 259 million yuan, a year-on-year increase of 37.45%, but a net loss of 125 million yuan, a slight increase in loss compared to the previous year [5] - The company has experienced continuous losses over the past three years, totaling nearly 400 million yuan, with net losses of 140 million yuan in 2022 and 127 million yuan in 2023 [5][9] Group 3: Internal Control Issues - The internal control audit revealed significant deficiencies, particularly in financial reporting and risk management, affecting the accuracy of revenue and cost accounting [2][4] - The company has been criticized for its accounting practices, specifically the correction of revenue recognition methods from "gross" to "net" due to non-compliance with accounting standards [2][4] Group 4: Market Reactions and Future Outlook - The stock price has seen significant volatility, peaking at 15.26 yuan per share earlier in the year before dropping to 7.76 yuan, reflecting investor concerns over the company's financial health and regulatory issues [9][10] - Experts suggest that the ongoing losses and regulatory scrutiny may lead to further declines in stock value and potential administrative penalties, impacting investor confidence and the company's reputation [4][10]